Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation
Abstract
Medicines receiving a conditional marketing authorisation through Medicines Adaptive Pathways to Patients (MAPPs) will be a challenge for payers. The ‘introduction’ of MAPPs is already seen by the European Medicines Agency (EMA) as a fait accompli, with payers not consulted or involved. However, once medicines are approved through MAPPs, they will be evaluated for funding by payers through different activities. These include Health Technology...
Paper Details
Title
Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation
Published Date
Aug 23, 2017
Journal
Volume
8
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History